Developer docs
API playgroundTry for free, no card

Search company profiles

Densitas

Full company profile

uuid0004bai

Namestring
Densitas
Legal namestring
Densitas Inc.
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Densitas is a Canadian-based, private healthcare AI company that builds and markets a mammography AI suite under the intelliMammo platform. The suite delivers automated breast density assessment (densityAI), image quality and positioning quality evaluation (qualityAI/intelliPGMI), breast cancer risk management (intelliRisk), and an AI assistant for technologist coaching (intelliMaven, a GPT-powered add-on). The technology processes standard DICOM 'for presentation' mammograms, integrates with PACS, RIS, and reporting platforms, and is positioned for compliance with FDA MQSA/EQUIP, CAR MAP, and NAPBC accreditation frameworks. The platform is deployed at health systems, provincial screening programs (notably Atlantic Canada), NHS trusts in the UK, and within research trials in Germany, and is distributed both via direct enterprise sales and through AI marketplaces (Nuance, Blackford) and integration partners (Intelerad, iCAD, ScreenPoint Medical, Ikonopedia, Three Palm Software, TeraRecon).

The company monetizes through enterprise SaaS subscriptions sold to mammography facilities and health systems via demo-led, direct field sales and channel partners; specific pricing is not publicly disclosed. Customer segments span hospital and independent mammography facilities, multi-facility health systems, provincial/national screening programs, breast cancer screening research programs, and high-risk breast clinics. Selected named customers and case studies include Nova Scotia Health, NorthShore University HealthSystem, Leeds Teaching Hospitals NHS Trust, TeleMammography Specialists, and RAD-AID International. The company has stated clinical outcomes such as mammograms meeting positioning criteria improving from approximately 51% to 86% under structured QI programs, and its algorithms have analyzed over 2 million mammograms cumulatively.

Densitas is led by founder and CEO Mo Abdolell and operates from Halifax, Nova Scotia, with regional sites for the U.S. and UK. Strategic direction since 2024 has emphasized product expansion (intelliMaven in April 2024, intelliRisk in November 2024), clinical evidence publication (MAMMO.IQ study in July 2025), and geographic expansion into continental Europe via the DIMASOS 2 procurement. Strategic and distribution partnerships with MTMI, ACR Learning Network, TungstenQI Partners, Mammography Educators, and Intelerad extend its reach and embed the platform into clinical QI workflows. Known outside investors include Innovacorp, MEDTEQ+, Real Ventures, Anges Quebec, and AQC Capital, with the most recent disclosed funding activity in 2019.

Short descriptiontext

Densitas is a Halifax-based healthcare AI company providing the intelliMammo platform, which delivers automated mammography image quality, breast density, positioning quality, and breast cancer risk assessments deployed at mammography facilities, health systems, provincial screening programs, and academic centers across North America, the UK, and Germany.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHalifax, Canada
HQ citystring
Halifax
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
mammography AI software, breast density assessment, mammography quality analytics, breast cancer risk assessment, radiology AI solutions
Industry3 codes
PRIMARYHDAAAEAH
Medical Imaging AI
SECONDARYHLAHABAF
Mammography & Breast Imaging Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
Product category
Medical Imaging AI / Mammography Analytics Software
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model1 record
1SaaS/Software Subscriptions
TypeSubscription Recurring
Description

Cloud-based AI platform delivered as subscription to mammography facilities, health systems, and breast imaging centers. Pricing likely per-facility or per-scan based on enterprise agreements.

densitashealth.ca
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels7 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 6 records shown
1intelliMammo®
Description

AI-powered mammography quality analytics platform for breast cancer screening, providing image quality assessment, breast density evaluation, and positioning optimization.

densitashealth.ca
+5 more records
Core offering1 text field

Densitas builds and sells the intelliMammo AI platform — a cloud-based, vendor-neutral mammography analytics suite that runs automated breast density, image quality, positioning quality, and breast cancer risk assessments on standard DICOM mammograms for every exam. The platform is sold via subscription to hospitals, breast imaging centers, health systems, teleradiology providers, and provincial/national screening programs, with seamless PACS/RIS integration and supporting modules for analytics, compliance, equipment QC, CE tracking, and a GPT-powered assistant.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Mammograms meeting positioning criteria improved from ~51% to 86% baseline with structured QI programs
+2 more records
Product overview1 text field

Densitas offers the Densitas Breast Imaging AI Suite — a unified, end-to-end platform-plus-modules architecture comprising the intelliMammo core platform, densityAI deep learning breast density algorithm, qualityAI image quality evaluation, intelliRisk breast cancer risk management, and intelliMaven GPT AI assistant. Supporting modules include positioning/proficiency, advanced analytics, CE Tracking, Equipment QC, and compliance workflows. The suite covers the full breast care continuum from image acquisition to program management, providing on-demand clinical intelligence for mammography quality, breast density, and breast cancer risk for every mammogram.

Product and service5 records
1intelliMammo
CategoryBreast imaging AI platform
Description

Core AI-powered platform for mammography quality that automatically generates breast density, clinical image quality, and breast cancer risk assessments for every mammogram. Provides real-time analytics for technologists at point-of-care and retrospective analytics for radiologists, QC technologists, and administrators at clinic and health system levels.

2densityAI
CategoryBreast density assessment AI
Description

Automated and standardized breast density assessment software using two distinct deep learning models that decouple quantitative percent mammographic density (0%-100%) from qualitative ACR BI-RADS 5th edition category (A, B, C, D). Processes 'for presentation' DICOM mammograms with seamless PACS integration.

3qualityAI
CategoryMammography image quality AI
Description

Mammography image quality evaluation software generating standardized, reproducible assessments aligned with Canadian Association of Radiologists Mammography Accreditation Program (CAR MAP) image quality criteria and FDA MQSA EQUIP requirements. Provides enterprise-wide evaluation with automated flagging of poor quality.

4intelliRisk
CategoryBreast cancer risk management
Description

High-risk breast cancer patient management platform that supports NAPBC accreditation. Integrates breast density with clinical factors to provide standardized, reproducible patient-specific breast cancer risk estimates for individualized screening strategies and supplemental imaging recommendations.

5intelliMaven
CategoryGenerative AI assistant
Description

GPT AI add-on to the intelliMammo platform that answers complex mammography questions in clear, easy-to-understand narrative language. Provides real-time expert feedback on positioning techniques to technologists and operational insights for radiologists and managers.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-22
Description

Strategic partnership combining Densitas' intelliMammo AI platform with TungstenQI's quality improvement methodology. Integrates AI-driven analytics with expert-guided interventions for sustainable mammography positioning improvement. Aims to help facilities refine positioning techniques, boost diagnostic accuracy, reduce unnecessary recalls, and improve patient outcomes through continuous QI programs.

2ACR Learning Network
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-11-25
Description

Collaboration with ACR Learning Network in the Mammography Positioning Improvement Collaborative to advance quality standards. Part of broader initiative to standardize mammography positioning across U.S. facilities using AI-driven analytics.

densitashealth.ca
3Medical Technology Management Institute (MTMI)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-10-02
Description

Strategic collaboration integrating MTMI's educational content including embedded positioning videos into intelliMammo solution. MTMI provides expert instruction across imaging modalities with highly rated mammography courses and cross-training boot camps. Joint telehealth solution for customized technologist training curriculum.

densitashealth.ca
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-04-28
Description

Province-wide deployment across Atlantic Canada including Horizon Health Network, Vitalité Health Network (New Brunswick), Health PEI (Prince Edward Island), Nova Scotia Health, and IWK Health. Groundbreaking intelliMammo AI platform deployment for screening mammography across multiple provinces.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-11-19
Description

First AI-powered telehealth technologist training platform. Co-founded by Louise Miller, world-renowned mammographer. Develops high-quality methods for breast imaging through education services and products. Provides live technologist training remotely informed by Densitas-generated technologist AI report cards.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-02-27
Description

Partnership to establish AI-based decision support program for breast health in medically underserved regions. Provides low-resource institutions with education, clinical support, and hands-on training for sustainable mammography practices. Addresses global breast health disparities through responsible AI deployment.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2019-10-21
Description

AI Marketplace accelerates AI development and adoption in medical imaging by connecting algorithm developers with subscribers' PACS, reporting, and worklist solutions across 6,500+ healthcare facilities and 70% of U.S. radiologists. Densitas densityai available through Nuance PowerScribe One and PowerScribe 360 Reporting. Also connected to Nuance Precision Imaging Network (PIN).

8DIMASOS 2 Trial (Germany)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-09-18
Description

densitas densityai deployed in up to 24 clinics throughout Germany for major breast cancer screening trial. Led by Prof. Dr. Sylvia H. Heywang-Köbrunner. Trial tests combined mammography/ultrasound exams for early cancer detection. Densitas software provides breast density measurements to identify women for supplemental screening.

densitashealth.ca
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2019-02-11
Description

International teleradiology services provider specialized in breast imaging. First U.S. beta user for densitas qualityai solution. Implementing densitas densityai for standardized breast density assessment. Over 60,000 women benefit annually through this partnership. Supports EQUIP guidelines compliance and real-time radiologist-to-technologist feedback.

10Intelerad
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Leading provider of medical imaging software and services. Headquartered in Raleigh, NC and Montreal, Quebec with over 900 employees in offices across six countries. Nearly 2,500 healthcare organizations rely on Intelerad products. Densitas integration enables enterprise imaging customers to access AI-powered mammography quality solutions.

densitashealth.ca
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Global leader in AI-powered mammography analysis for breast cancer detection, density assessment, and risk evaluation. ProFound Breast Health Suite available in over 50 countries serving thousands of providers and millions of patients. Channel partnership for complementary market access.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Transpara AI for breast cancer risk assessment and screening workflow. Developed by machine learning and image analysis experts with input from world-renowned breast imagers. Partnership for integrated market offerings.

Strategic tierCoreTypeTechnology or Integration
Description

AI platform providing actionable imaging information to reduce cost of care while improving diagnostic confidence and patient outcomes. Relevancy engine determines which studies to send each clinical application. Densitas integrated into Blackford Platform and Curated Marketplace for AI interoperability.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Volpara provides AI-driven breast density, image quality, and risk assessment software used by mammography clinics and health systems—competing with Densitas across the same densityAI / qualityAI use cases and a comparable SaaS go-to-market.

TypeEmerging player
Description

Lunit's INSIGHT MMG is an FDA-cleared breast cancer detection AI used in mammography workflows. While Lunit is broader across multiple imaging modalities, its mammography product is a direct competitor for breast imaging AI budget and radiology workflow integration.

TypeBroad incumbent
Description

Hologic is the dominant mammography hardware vendor (3Dimensions, Genius AI) and offers adjacent AI capabilities. While not a direct Densitas competitor on density/positioning software, Hologic's installed base and bundled AI offerings shape Densitas' competitive environment at the system level.

TypeDirect peer
Description

ScreenPoint's Transpara AI provides breast cancer detection, risk assessment, and screening workflow support—the most directly overlapping clinical use case with Densitas. Densitas lists ScreenPoint as a channel partner, confirming product-level comparability for breast imaging AI buyers.

TypeEmerging player
Description

Therapixel's MammoScreen is an FDA-cleared AI for mammography reading workflow, similar to densityAI and risk assessment modules. Therapixel is a focused European competitor pursuing U.S. market entry, comparable to Densitas in size and specialization.

TypeBroad incumbent
Description

GE HealthCare sells mammography systems (Senographe Pristina) and the iCAD-licensed MIA algorithm, and operates broader imaging IT platforms (Edison). As a broad incumbent, it competes with Densitas both at the modality-AI layer and at the imaging IT/integration layer.

TypeDirect peer
Description

iCAD is a direct competitor offering AI for breast density, cancer detection, and risk assessment via the ProFound suite. Both companies target mammography facilities and breast imaging centers and even operate as channel partners—making iCAD the closest head-to-head comparison for Densitas.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration9 records

Each record includes

Title, Type, Description, Source

AI capability10 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Densitas

Medical Imaging AI / Mammography Analytics Softwaredensitashealth.ca

Densitas is a Halifax-based healthcare AI company providing the intelliMammo platform, which delivers automated mammography image quality, breast density, positioning quality, and breast cancer risk assessments deployed at mammography facilities, health systems, provincial screening programs, and academic centers across North America, the UK, and Germany.

What Densitas does

Densitas is a Canadian-based, private healthcare AI company that builds and markets a mammography AI suite under the intelliMammo platform. The suite delivers automated breast density assessment (densityAI), image quality and positioning quality evaluation (qualityAI/intelliPGMI), breast cancer risk management (intelliRisk), and an AI assistant for technologist coaching (intelliMaven, a GPT-powered add-on). The technology processes standard DICOM 'for presentation' mammograms, integrates with PACS, RIS, and reporting platforms, and is positioned for compliance with FDA MQSA/EQUIP, CAR MAP, and NAPBC accreditation frameworks. The platform is deployed at health systems, provincial screening programs (notably Atlantic Canada), NHS trusts in the UK, and within research trials in Germany, and is distributed both via direct enterprise sales and through AI marketplaces (Nuance, Blackford) and integration partners (Intelerad, iCAD, ScreenPoint Medical, Ikonopedia, Three Palm Software, TeraRecon).

The company monetizes through enterprise SaaS subscriptions sold to mammography facilities and health systems via demo-led, direct field sales and channel partners; specific pricing is not publicly disclosed. Customer segments span hospital and independent mammography facilities, multi-facility health systems, provincial/national screening programs, breast cancer screening research programs, and high-risk breast clinics. Selected named customers and case studies include Nova Scotia Health, NorthShore University HealthSystem, Leeds Teaching Hospitals NHS Trust, TeleMammography Specialists, and RAD-AID International. The company has stated clinical outcomes such as mammograms meeting positioning criteria improving from approximately 51% to 86% under structured QI programs, and its algorithms have analyzed over 2 million mammograms cumulatively.

Densitas is led by founder and CEO Mo Abdolell and operates from Halifax, Nova Scotia, with regional sites for the U.S. and UK. Strategic direction since 2024 has emphasized product expansion (intelliMaven in April 2024, intelliRisk in November 2024), clinical evidence publication (MAMMO.IQ study in July 2025), and geographic expansion into continental Europe via the DIMASOS 2 procurement. Strategic and distribution partnerships with MTMI, ACR Learning Network, TungstenQI Partners, Mammography Educators, and Intelerad extend its reach and embed the platform into clinical QI workflows. Known outside investors include Innovacorp, MEDTEQ+, Real Ventures, Anges Quebec, and AQC Capital, with the most recent disclosed funding activity in 2019.

Densitas firmographics

Firmographics
Name
Densitas
Legal name
Densitas Inc.
Website
https://densitashealth.ca
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
Densitas is a Halifax-based healthcare AI company providing the intelliMammo platform, which delivers automated mammography image quality, breast density, positioning quality, and breast cancer risk assessments deployed at mammography facilities, health systems, provincial screening programs, and academic centers across North America, the UK, and Germany.
Ownership category
akta.pro rank

Densitas industry classification

Industry
Product category
Medical Imaging AI / Mammography Analytics Software
akta.pro industry
PRIMARYHDAAAEAH
Medical Imaging AI
SECONDARYHLAHABAF
Mammography & Breast Imaging Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability

Keywords

  • Mammography AI software
  • Breast density assessment
  • Mammography quality analytics
  • Breast cancer risk assessment
  • Radiology AI solutions

Where Densitas is headquartered

Location

Headquarters

HQ city
Halifax
HQ country
Canada
HQ region
North America

Offices2 records

Markets served

Densitas business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. SaaS/Software Subscriptions: Cloud-based AI platform delivered as subscription to mammography facilities, health systems, and breast imaging centers. Pricing likely per-facility or per-scan based on enterprise agreements.

Go-to-market motion3 records

Distribution channels7 records

Marketing channels7 records

Densitas product offering

Product offering

Core offering

Densitas builds and sells the intelliMammo AI platform — a cloud-based, vendor-neutral mammography analytics suite that runs automated breast density, image quality, positioning quality, and breast cancer risk assessments on standard DICOM mammograms for every exam. The platform is sold via subscription to hospitals, breast imaging centers, health systems, teleradiology providers, and provincial/national screening programs, with seamless PACS/RIS integration and supporting modules for analytics, compliance, equipment QC, CE tracking, and a GPT-powered assistant.

Product overview

Densitas offers the Densitas Breast Imaging AI Suite — a unified, end-to-end platform-plus-modules architecture comprising the intelliMammo core platform, densityAI deep learning breast density algorithm, qualityAI image quality evaluation, intelliRisk breast cancer risk management, and intelliMaven GPT AI assistant. Supporting modules include positioning/proficiency, advanced analytics, CE Tracking, Equipment QC, and compliance workflows. The suite covers the full breast care continuum from image acquisition to program management, providing on-demand clinical intelligence for mammography quality, breast density, and breast cancer risk for every mammogram.

Differentiator

Problem solved

Functional benefit

Brands

  • intelliMammo®: AI-powered mammography quality analytics platform for breast cancer screening, providing image quality assessment, breast density evaluation, and positioning optimization.
  • densityAI™
  • qualityAI™
  • intelliRisk™
  • intelliMaven™
  • intelliPGMI™

Products and services

  • intelliMammo Core AI-powered platform for mammography quality that automatically generates breast density, clinical image quality, and breast cancer risk assessments for every mammogram. Provides real-time analytics for technologists at point-of-care and retrospective analytics for radiologists, QC technologists, and administrators at clinic and health system levels.
  • densityAI Automated and standardized breast density assessment software using two distinct deep learning models that decouple quantitative percent mammographic density (0%-100%) from qualitative ACR BI-RADS 5th edition category (A, B, C, D). Processes 'for presentation' DICOM mammograms with seamless PACS integration.
  • qualityAI Mammography image quality evaluation software generating standardized, reproducible assessments aligned with Canadian Association of Radiologists Mammography Accreditation Program (CAR MAP) image quality criteria and FDA MQSA EQUIP requirements. Provides enterprise-wide evaluation with automated flagging of poor quality.
  • intelliRisk High-risk breast cancer patient management platform that supports NAPBC accreditation. Integrates breast density with clinical factors to provide standardized, reproducible patient-specific breast cancer risk estimates for individualized screening strategies and supplemental imaging recommendations.
  • intelliMaven GPT AI add-on to the intelliMammo platform that answers complex mammography questions in clear, easy-to-understand narrative language. Provides real-time expert feedback on positioning techniques to technologists and operational insights for radiologists and managers.

Quantifiable outcome

  • Mammograms meeting positioning criteria improved from ~51% to 86% baseline with structured QI programs
  • +2 more outcomes

Companies that use Densitas

Customer profile

Named customers11 records

Segments5 records

Ideal customer profiles3 records

Densitas technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration9 records

AI capability10 records

Feature7 records

Densitas partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core and minor.

  • TungstenQI PartnerscoreStrategic or Co-development Partner · 22 April 2025Strategic partnership combining Densitas' intelliMammo AI platform with TungstenQI's quality improvement methodology. Integrates AI-driven analytics with expert-guided interventions for sustainable mammography positioning improvement. Aims to help facilities refine positioning techniques, boost diagnostic accuracy, reduce unnecessary recalls, and improve patient outcomes through continuous QI programs.
  • ACR Learning NetworkcoreStrategic or Co-development Partner · 25 November 2024Collaboration with ACR Learning Network in the Mammography Positioning Improvement Collaborative to advance quality standards. Part of broader initiative to standardize mammography positioning across U.S. facilities using AI-driven analytics.
  • Medical Technology Management Institute (MTMI)coreStrategic or Co-development Partner · 2 October 2024Strategic collaboration integrating MTMI's educational content including embedded positioning videos into intelliMammo solution. MTMI provides expert instruction across imaging modalities with highly rated mammography courses and cross-training boot camps. Joint telehealth solution for customized technologist training curriculum.
  • Atlantic Canada Health NetworkscoreChannel Partner/ Reseller/ Distributor · 28 April 2021Province-wide deployment across Atlantic Canada including Horizon Health Network, Vitalité Health Network (New Brunswick), Health PEI (Prince Edward Island), Nova Scotia Health, and IWK Health. Groundbreaking intelliMammo AI platform deployment for screening mammography across multiple provinces.
  • Mammography EducatorscoreStrategic or Co-development Partner · 19 November 2020First AI-powered telehealth technologist training platform. Co-founded by Louise Miller, world-renowned mammographer. Develops high-quality methods for breast imaging through education services and products. Provides live technologist training remotely informed by Densitas-generated technologist AI report cards.
  • RAD-AID InternationalcoreStrategic or Co-development Partner · 27 February 2020Partnership to establish AI-based decision support program for breast health in medically underserved regions. Provides low-resource institutions with education, clinical support, and hands-on training for sustainable mammography practices. Addresses global breast health disparities through responsible AI deployment.
  • Nuance CommunicationscoreTechnology or Integration · 21 October 2019AI Marketplace accelerates AI development and adoption in medical imaging by connecting algorithm developers with subscribers' PACS, reporting, and worklist solutions across 6,500+ healthcare facilities and 70% of U.S. radiologists. Densitas densityai available through Nuance PowerScribe One and PowerScribe 360 Reporting. Also connected to Nuance Precision Imaging Network (PIN).
  • DIMASOS 2 Trial (Germany)coreStrategic or Co-development Partner · 18 September 2019densitas densityai deployed in up to 24 clinics throughout Germany for major breast cancer screening trial. Led by Prof. Dr. Sylvia H. Heywang-Köbrunner. Trial tests combined mammography/ultrasound exams for early cancer detection. Densitas software provides breast density measurements to identify women for supplemental screening.
  • TeleMammography SpecialistscoreChannel Partner/ Reseller/ Distributor · 11 February 2019International teleradiology services provider specialized in breast imaging. First U.S. beta user for densitas qualityai solution. Implementing densitas densityai for standardized breast density assessment. Over 60,000 women benefit annually through this partnership. Supports EQUIP guidelines compliance and real-time radiologist-to-technologist feedback.
  • InteleradminorChannel Partner/ Reseller/ DistributorLeading provider of medical imaging software and services. Headquartered in Raleigh, NC and Montreal, Quebec with over 900 employees in offices across six countries. Nearly 2,500 healthcare organizations rely on Intelerad products. Densitas integration enables enterprise imaging customers to access AI-powered mammography quality solutions.
  • iCAD, Inc.minorChannel Partner/ Reseller/ DistributorGlobal leader in AI-powered mammography analysis for breast cancer detection, density assessment, and risk evaluation. ProFound Breast Health Suite available in over 50 countries serving thousands of providers and millions of patients. Channel partnership for complementary market access.
  • ScreenPoint MedicalminorChannel Partner/ Reseller/ DistributorTranspara AI for breast cancer risk assessment and screening workflow. Developed by machine learning and image analysis experts with input from world-renowned breast imagers. Partnership for integrated market offerings.
  • BlackfordcoreTechnology or IntegrationAI platform providing actionable imaging information to reduce cost of care while improving diagnostic confidence and patient outcomes. Relevancy engine determines which studies to send each clinical application. Densitas integrated into Blackford Platform and Curated Marketplace for AI interoperability.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Densitas competitors and assessment

Company assessment

Direct peers

  • Volpara Health: Volpara provides AI-driven breast density, image quality, and risk assessment software used by mammography clinics and health systems—competing with Densitas across the same densityAI / qualityAI use cases and a comparable SaaS go-to-market.
  • ScreenPoint Medical: ScreenPoint's Transpara AI provides breast cancer detection, risk assessment, and screening workflow support—the most directly overlapping clinical use case with Densitas. Densitas lists ScreenPoint as a channel partner, confirming product-level comparability for breast imaging AI buyers.
  • iCAD (ProFound Breast Health Suite): iCAD is a direct competitor offering AI for breast density, cancer detection, and risk assessment via the ProFound suite. Both companies target mammography facilities and breast imaging centers and even operate as channel partners—making iCAD the closest head-to-head comparison for Densitas.

Emerging players

  • Lunit: Lunit's INSIGHT MMG is an FDA-cleared breast cancer detection AI used in mammography workflows. While Lunit is broader across multiple imaging modalities, its mammography product is a direct competitor for breast imaging AI budget and radiology workflow integration.
  • Therapixel: Therapixel's MammoScreen is an FDA-cleared AI for mammography reading workflow, similar to densityAI and risk assessment modules. Therapixel is a focused European competitor pursuing U.S. market entry, comparable to Densitas in size and specialization.

Broad incumbents

  • Hologic: Hologic is the dominant mammography hardware vendor (3Dimensions, Genius AI) and offers adjacent AI capabilities. While not a direct Densitas competitor on density/positioning software, Hologic's installed base and bundled AI offerings shape Densitas' competitive environment at the system level.
  • GE HealthCare: GE HealthCare sells mammography systems (Senographe Pristina) and the iCAD-licensed MIA algorithm, and operates broader imaging IT platforms (Edison). As a broad incumbent, it competes with Densitas both at the modality-AI layer and at the imaging IT/integration layer.

Peers

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Densitas social profiles

Digital presence

Densitas compliance and trust

Trust signal

Compliance2 records

Densitas financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Densitas leadership team

Management profile

Number of profiles

Profiles1 record

Densitas funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Densitas M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Densitas

What does Densitas do?

Densitas builds and sells the intelliMammo AI platform — a cloud-based, vendor-neutral mammography analytics suite that runs automated breast density, image quality, positioning quality, and breast cancer risk assessments on standard DICOM mammograms for every exam. The platform is sold via subscription to hospitals, breast imaging centers, health systems, teleradiology providers, and provincial/national screening programs, with seamless PACS/RIS integration and supporting modules for analytics, compliance, equipment QC, CE tracking, and a GPT-powered assistant.

Is Densitas a public or private company?

Densitas is a private company. It is classified as venture growth investor backed and is currently operating.

When was Densitas founded?

Densitas was founded in 2015. It employs 11 to 50 people.

Where is Densitas based?

Densitas is headquartered in Halifax, Canada, in the North America region.

How does Densitas make money?

One revenue line is on record: saaS/Software Subscriptions.

Who are Densitas's main competitors?

Direct peers on record are Volpara Health, ScreenPoint Medical and iCAD (ProFound Breast Health Suite). Emerging players are Lunit and Therapixel. Broad incumbents are Hologic and GE HealthCare. DeepHealth (RadNet subsidiary) is listed as a peer.

Does Densitas have an API?

No public API is recorded for Densitas.

What industry is Densitas in?

Densitas's product category is Medical Imaging AI / Mammography Analytics Software. Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI, with a secondary code of HLAHABAF, Mammography & Breast Imaging Systems.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireiCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual SymposiumiCAD will showcase its ProFound Cloud, powered by Google Cloud and Health AI, and its partnership with Densitas at the SBI symposium in Montreal. The company also highlights new ProFound Detection Workstation features for streamlined mammogram interpretation. A philanthropic partnership with RAD-AID International will deploy ProFound AI in Guyana.PR NewswireRepousser les limites en matière de dépistage du cancer du sein : Densitas® et ScreenPoint Medical s'associent pour offrir de meilleurs résultats aux patientsDensitas® Inc. announced a strategic partnership with ScreenPoint Medical on June 8, 2023, to combine their respective AI mammography solutions — Densitas intelliMammo™ and ScreenPoint Transpara® — for use by mammography service providers. The collaboration aims to address the problem of poor image quality in mammograms, where roughly 50% fail to meet quality standards primarily due to patient positioning errors. Together, the two AI platforms intend to improve breast cancer detection accuracy, reduce unnecessary procedures from false positives, and support radiologist decision-making.NewswireDensitas Connects to Nuance Precision Imaging Network to Empower Collaborative Care Teams and Improve Patient Outcomes with Workflow-Integrated AIDensitas connected to Nuance Precision Imaging Network, making its intelliMammo platform accessible to over 10,000 US healthcare facilities. The platform provides FDA/ACR compliant AI insights for breast density, cancer risk, and image quality. The connection aims to improve collaborative care and patient outcomes.PR NewswireDensitas® Announces New Director, Global Sales and Operations to Lead Market ExpansionDensitas® Inc., a Halifax-based provider of AI technologies for digital mammography and breast screening, appointed Alexandra Bade as Director, Global Sales and Operations to lead the company's global market expansion. Bade brings 18 years of experience from Intelerad Medical Systems, where she most recently built and led the Inside Sales team to exponential growth. The company will showcase its AI solutions at the upcoming Radiological Society of North America annual meeting, November 28–December 2, 2021.PR NewswireDensitas® kündigt neuen Director, Global Sales and Operations an, um die Marktexpansion zu leitenDensitas® Inc., a global provider of AI technologies for digital mammography and breast screening, appointed Alexandra Bade as Director, Global Sales and Operations to lead its global market expansion. Bade brings 18 years of experience from Intelerad Medical Systems, where she built and led an Inside Sales Team through exponential growth. The company stated that her international healthcare systems expertise will support its accelerated growth in target markets.EntrevestorEntrevestorDensitas deployed its intelliMammo AI mammography software at a Guyana hospital with nonprofit RAD-AID International, which trained technicians for the program. The software consolidates three offerings measuring breast density, cancer risk, and image quality. Guyana's age-adjusted breast cancer death rate was 24.36 per 100,000 women in 2018.PR NewswireDensitas® Deploys intelliMammo™ A.I. Platform in Partnership with RAD-AID International for Breast Screening Quality Assurance and Technologist Training in GuyanaDensitas® Inc. deployed its intelliMammo™ A.I. software platform at Georgetown Public Hospital in Guyana in partnership with RAD-AID International to support breast cancer screening quality assurance and technologist training. The initiative aims to address Guyana's higher breast cancer death rate (24.36 per 100,000 women in 2018 versus 17.49 in the United States) by providing A.I.-driven clinical decision support and mammography-specific workflows. The deployment will empower technologists with positioning error identification, integrated training materials, and advanced analytics for continuous quality assurance in understaffed and under-resourced regions.PR NewswireDensitas® setzt intelliMammo™ A.I. ein Plattform in Partnerschaft mit RAD-AID International für die Qualitätssicherung von Brustscreenings und die Ausbildung von Technologen in GuyanaDensitas® Inc., a global AI provider for digital mammography, partnered with RAD-AID International to deploy its intelliMammo™ software platform at Georgetown Public Hospital in Guyana for breast cancer screening quality assurance and technologist training. Guyana launched its first public sector breast screening program in 2019, addressing an age-adjusted breast cancer death rate of 24.36 per 100,000 women—significantly higher than the 17.49 in the United States. The initiative aims to improve early detection by integrating AI-driven clinical decision support to reduce healthcare disparities in under-resourced regions.EntrevestorEntrevestorEight Atlantic Canadian companies were named to Scale-Up Hub: Atlanta, a program helping them sell in the U.S. Southeast. The program, launched by Nova Scotia Business Inc., is funded by federal and provincial governments and will run virtually until travel is allowed. The cohort includes firms like 902HipHop, Black Arcs, and Densitas.EntrevestorEntrevestorDensitas, a Canadian AI mammography software firm, signed deals with New Brunswick, P.E.I., and Nova Scotia governments to deploy its intelliMammo platform in provincial hospitals and clinics. The company reports sales recovery in the U.S. market and has hired six new employees, with more hires planned.